NP49425 Generic and Biosimilar Transition Medicines
Estimated value
—
Awarded value
—
Suppliers
31
Lots
1
Published
30 Mar 2026
Description
The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:827046)
Scope
- Reference
- ocds-h6vhtk-0581ea
- Commercial tool
- Standalone contract
- Contract dates
The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-five (35) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Supply Chain | 5 | quality | — |
| — | 95 | price | — |
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—